Study of Oral ALXN1840 at 2 Dose Strengths in Healthy Adults

NCT05303324 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ALXN1840

Sponsor

Alexion Pharmaceuticals, Inc.